Trials / Completed
CompletedNCT04990310
Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants
An Open Label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-CORT113176 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Corcept Therapeutics · Industry
- Sex
- Male
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the mass balance recovery and metabolite profile, and will identify metabolite structures following a single oral dose of \[14C\]-CORT113176 in healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]-CORT113176 | \[14C\]-CORT113176 450 mg lipid formulation capsule for oral administration containing not more than 3.37 megaBequerel 14C. |
Timeline
- Start date
- 2021-08-18
- Primary completion
- 2021-09-20
- Completion
- 2021-09-20
- First posted
- 2021-08-04
- Last updated
- 2021-11-24
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04990310. Inclusion in this directory is not an endorsement.